Good news for hepatorenal syndrome

Hepatology

Volumn 36, Issue 2, 2002, Pages 504-506

  Ginès, Pere ^a   Guevara, Monica ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE REGULATION; DISEASE COURSE; EDITORIAL; HEPATORENAL SYNDROME; HUMAN; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS;

HEPATORENAL SYNDROME; HUMANS; VASOCONSTRICTOR AGENTS;

EID: 0036322281     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.35273     Document Type: Editorial

References (21)

1. Electrolyte and circulatory changes in terminal liver failure
2. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem
3. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis
4. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites
5. Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion
6. Transjugular intrahepatic portosystemic shunts in hepatorenal syndrome: Effects on renal function and vasoactive systems
7. Long-term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: A phase II study
8. Terlipressin plus albumin infusion: An effective and safe therapy of hepatorenal syndrome
9. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: Results of a prospective, randomized, controlled clinical trial
10. Hepatorenal syndrome: Pathogenesis and treatment
11. Hepatorenal syndrome
12. Effects of noradrenalin and albumin in patients with type 1 hepatorenal syndrome: A pilot study
13. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide
14. Norepinephrine-induced acture renal failure: A reversible ischemic model of acute renal failure
15. Norepinephrine alone versus norepinephrine plus low-dose dopamine: Enhanced renal blood flow with combination pressor therapy
16. Mechanisms involved in the renal response to intravenous and renal artery infusions of noradrenaline in conscious dogs
17. Noradrenaline and the kidney: Friends or foes?
18. The pathogenesis of vasodilatory shock
19. Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: A retrospective study
20. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome. Efficacy and outcome
21. Long-term survial and renal function following liver transplantation in patients with and without hepatorenal syndrome - Experience in 300 patients